able semaglutide Compounded Semaglutide 1.75mg - 4 injections

Frequently Asked Questions As of July 2026, retatrutide has completed four Phase 3 readouts: TRIUMPH-4 (28.7% weight loss in knee OA population, December 2025), TRIUMPH-1 (28.3% weight loss in 2,339 general obesity patients, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c and 16.8% weight loss in 537 T2D patients, June 2026), and the TRIUMPH-1 sleep apnea substudy (60.6% AHI reduction, June 2026)

Dose consistency matters because semaglutide works through dose escalation protocolsyour prescriber gradually increases your weekly dose over weeks to reach therapeutic levels while your body adapts

Rotating between the abdomen, thigh, and upper arm helps reduce skin irritation

See FDAs compounding policy clarification

227, no